Qidu Pharma became the first company in China to receive approval for an enzymatic synthesis process for L-carnitine API.
Netizen “Free as the Wind” wrote: “Chasing dreams across mountains and seas, we don’t feel the distance; though the road ahead stretches long, we stride ahead boldly. Let us summon the courage of a galloping steed, unleash the vitality of charging horses, and keep motivated like a horse rushing forward. Together, let’s fight for our dreams and work hard for our happiness, turning a grand vision into a beautiful reality. When each of our ‘small families’ is brimming with warmth and energy, the big family of Qidu Pharma will thrive and grow more prosperous with every passing day.”
Recommended reading
-
January 20, 2025Top Ten Events of Qidu Pharmaceutical Group in 2025 Announced
-
June 17, 2026Qidu Pharma’s intelligent production project for oral preparations with an annual capacity of 10 billion tablets/granules passed the GMP on-site inspection.
-
June 25, 2026Qidu Biotech Approved to Establish "Zibo (Qidu) Cell Preparation Center and Tissue Cell Bank"
-
June 23, 2026Zheng Jiaqing was honored as a National Model Worker
-
June 23, 2026Qidu Pharma was designated as one of the “National Outstanding Excellence-Level Smart Factories”
-
June 23, 2026Qidu Pharma was included in the “Shandong Top 100 Private Enterprises” series of rankings.
-
June 23, 2026Qidu Pharma was listed among China’s top 100 pharmaceutical companies by main business revenue.